{"count": 5, "results": [{"_id": "15145635", "pmid": 15145635, "title": "Oral simvastatin treatment in relapsing-remitting multiple sclerosis.", "journal": "Lancet", "authors": ["Vollmer T", "Key L", "Durkalski V", "Tyor W", "Corboy J", "Markovic-Plese S", "Preiningerova J", "Rizzo M", "Singh I"], "date": "2004-05-15T00:00:00Z", "doi": "10.1016/S0140-6736(04)16205-3", "meta_date_publication": "2004 May 15", "meta_volume": "363", "meta_issue": "9421", "meta_pages": "1607-8", "score": 50088.35, "text_hl": "Oral @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ treatment in @<m>DISEASE_Multiple_Sclerosis_Relapsing_Remitting</m> @DISEASE_MESH:D020529 @@@relapsing-remitting multiple sclerosis@@@.", "citations": {"NLM": "Vollmer T, Key L, Durkalski V, Tyor W, Corboy J, Markovic-Plese S, Preiningerova J, Rizzo M, Singh I. Oral simvastatin treatment in relapsing-remitting multiple sclerosis. Lancet. 2004 May 15;363(9421):1607-8. PMID: 15145635", "BibTeX": "@article{15145635, title={Oral simvastatin treatment in relapsing-remitting multiple sclerosis.}, author={Vollmer T and Key L and Durkalski V and Tyor W and Corboy J and Markovic-Plese S and Preiningerova J and Rizzo M and Singh I}, journal={Lancet}, volume={363}, number={9421}, pages={1607-8}}"}}, {"_id": "23076801", "pmid": 23076801, "title": "Simvastatin inhibits secretion of Th17-polarizing cytokines and antigen presentation by DCs in patients with relapsing remitting multiple sclerosis.", "journal": "Eur J Immunol", "authors": ["Zhang X", "Tao Y", "Wang J", "Garcia-Mata R", "Markovic-Plese S"], "date": "2013-01-01T00:00:00Z", "doi": "10.1002/eji.201242566", "meta_date_publication": "2013 Jan", "meta_volume": "43", "meta_issue": "1", "meta_pages": "281-9", "score": 50069.04, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ inhibits secretion of Th17-polarizing cytokines and antigen presentation by DCs in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Multiple_Sclerosis_Relapsing_Remitting</m> @DISEASE_MESH:D020529 @@@relapsing remitting multiple sclerosis@@@.", "citations": {"NLM": "Zhang X, Tao Y, Wang J, Garcia-Mata R, Markovic-Plese S. Simvastatin inhibits secretion of Th17-polarizing cytokines and antigen presentation by DCs in patients with relapsing remitting multiple sclerosis. Eur J Immunol. 2013 Jan;43(1):281-9. PMID: 23076801", "BibTeX": "@article{23076801, title={Simvastatin inhibits secretion of Th17-polarizing cytokines and antigen presentation by DCs in patients with relapsing remitting multiple sclerosis.}, author={Zhang X and Tao Y and Wang J and Garcia-Mata R and Markovic-Plese S}, journal={Eur J Immunol}, volume={43}, number={1}, pages={281-9}}"}}, {"_id": "21742556", "pmid": 21742556, "title": "Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial.", "journal": "Lancet Neurol", "authors": ["Sorensen PS", "Lycke J", "Erälinna JP", "Edland A", "Wu X", "Frederiksen JL", "Oturai A", "Malmeström C", "Stenager E", "Sellebjerg F", "Sondergaard HB", "SIMCOMBIN study investigators"], "date": "2011-08-01T00:00:00Z", "doi": "10.1016/S1474-4422(11)70144-2", "meta_date_publication": "2011 Aug", "meta_volume": "10", "meta_issue": "8", "meta_pages": "691-701", "score": 50066.227, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ as add-on therapy to interferon beta-1a for @<m>DISEASE_Multiple_Sclerosis_Relapsing_Remitting</m> @DISEASE_MESH:D020529 @@@relapsing-remitting multiple sclerosis@@@ (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial.", "citations": {"NLM": "Sorensen PS, Lycke J, Erälinna JP, Edland A, Wu X, Frederiksen JL, Oturai A, Malmeström C, Stenager E, Sellebjerg F, Sondergaard HB, SIMCOMBIN study investigators. Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial. Lancet Neurol. 2011 Aug;10(8):691-701. PMID: 21742556", "BibTeX": "@article{21742556, title={Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial.}, author={Sorensen PS and Lycke J and Erälinna JP and Edland A and Wu X and Frederiksen JL and Oturai A and Malmeström C and Stenager E and Sellebjerg F and Sondergaard HB and SIMCOMBIN study investigators}, journal={Lancet Neurol}, volume={10}, number={8}, pages={691-701}}"}}, {"_id": "20488825", "pmid": 20488825, "title": "Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.", "journal": "Mult Scler", "authors": ["Togha M", "Karvigh SA", "Nabavi M", "Moghadam NB", "Harirchian MH", "Sahraian MA", "Enzevaei A", "Nourian A", "Ghanaati H", "Firouznia K", "Jannati A", "Shekiba M"], "date": "2010-07-01T00:00:00Z", "doi": "10.1177/1352458510369147", "meta_date_publication": "2010 Jul", "meta_volume": "16", "meta_issue": "7", "meta_pages": "848-54", "score": 50065.574, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ treatment in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Multiple_Sclerosis_Relapsing_Remitting</m> @DISEASE_MESH:D020529 @@@relapsing-remitting multiple sclerosis@@@ receiving @GENE_IFNB1 @GENE_3456 @@@interferon beta@@@ 1a: a double-blind randomized controlled trial.", "citations": {"NLM": "Togha M, Karvigh SA, Nabavi M, Moghadam NB, Harirchian MH, Sahraian MA, Enzevaei A, Nourian A, Ghanaati H, Firouznia K, Jannati A, Shekiba M. Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial. Mult Scler. 2010 Jul;16(7):848-54. PMID: 20488825", "BibTeX": "@article{20488825, title={Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.}, author={Togha M and Karvigh SA and Nabavi M and Moghadam NB and Harirchian MH and Sahraian MA and Enzevaei A and Nourian A and Ghanaati H and Firouznia K and Jannati A and Shekiba M}, journal={Mult Scler}, volume={16}, number={7}, pages={848-54}}"}}, {"_id": "21856936", "pmid": 21856936, "title": "Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosis.", "journal": "J Immunol", "authors": ["Zhang X", "Tao Y", "Troiani L", "Markovic-Plese S"], "date": "2011-09-15T00:00:00Z", "doi": "10.4049/jimmunol.1100580", "meta_date_publication": "2011 Sep 15", "meta_volume": "187", "meta_issue": "6", "meta_pages": "3431-7", "score": 50060.86, "text_hl": "Subsequent to the clinical trial of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Multiple_Sclerosis_Relapsing_Remitting</m> @DISEASE_MESH:D020529 @@@relapsing remitting multiple sclerosis@@@ (@<m>DISEASE_Multiple_Sclerosis_Relapsing_Remitting</m> @DISEASE_MESH:D020529 @@@RR MS@@@), which demonstrated the ability of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ to inhibit new @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ @DISEASE_Central_Nervous_System_Diseases @DISEASE_MESH:D002493 @@@CNS lesion@@@ formation, the current in vitro study has characterized the mechanisms through which @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ inhibits Th17 cell differentiation. ", "citations": {"NLM": "Zhang X, Tao Y, Troiani L, Markovic-Plese S. Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosis. J Immunol. 2011 Sep 15;187(6):3431-7. PMID: 21856936", "BibTeX": "@article{21856936, title={Simvastatin inhibits IFN regulatory factor 4 expression and Th17 cell differentiation in CD4+ T cells derived from patients with multiple sclerosis.}, author={Zhang X and Tao Y and Troiani L and Markovic-Plese S}, journal={J Immunol}, volume={187}, number={6}, pages={3431-7}}"}}]}